Altria Holds 2025 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $1.02 Per Share
RICHMOND, Va.–(BUSINESS WIRE)–$MO #Altria–Altria Group, Inc. (Altria) (NYSE: MO) held our 2025 Annual Meeting of Shareholders (Annual Meeting)... Read more.
Evolution of Extended Reality (XR) in Retail Markets Global Report 2024-2025 & 2030: Opportunities in Evangelization, Innovations in Wearables, Partnership Expansion, Shopping Gamification, Metaverse – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Evolution of Extended Reality (XR) in Retail, Global, 2024-2030” report has been added to ResearchAndMarkets.com’s... Read more.
MTUS Investors Have Opportunity to Join Metallus Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of... Read more.
CEM Benchmarking Releases New Research on Pension Administration Costs
TORONTO–(BUSINESS WIRE)–CEM Benchmarking, a leading provider of data and insights to institutional investors, has released a comprehensive study titled... Read more.
LANDSEA HOMES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landsea Homes Corporation – LSEA
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
BlackRock Declares Quarterly Dividend of $5.21 on Common Stock
NEW YORK–(BUSINESS WIRE)–BlackRock, Inc. (NYSE:BLK) today announced that its Board of Directors has declared a quarterly cash dividend of $5.21 per share... Read more.
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months Results published in The New England Journal... Read more.
First Patient Treated with Personalized CRISPR Therapy, Developed in Just Six Months
Leaders of the gene-editing field join forces to develop and administer the first on-demand CRISPR therapy for an infant with a rare metabolic disease. BERKELEY,... Read more.
GCT Semiconductor Announces $11 Million Registered Direct Offering
SAN JOSE, Calif.–(BUSINESS WIRE)–#4G–GCT Semiconductor Holding, Inc. (“GCT” or the “Company”) (NYSE: GCTS), a leading designer and supplier... Read more.
Liberty All-Star® Equity Fund April 2025 Monthly Update
BOSTON–(BUSINESS WIRE)–Below is the April 2025 Monthly Update for the Liberty All-Star Equity Fund (NYSE: USA). Liberty All-Star Equity Fund Ticker:... Read more.